|
Asbestos Exposure Lawyers - Successful Litigation - Mesothelioma Attorneys |
| Asbestos & Mesothelioma News |
|
 |
Asbestos & Mesothelioma Headlines
More Asbestos News
Asbestos victims take campaign to Hardie investors
ABC Online - Sept, 2004
Cuyahoga County Limits Asbestos Court To Those Who Are Sick
NewsNet5.com, OH - Sept., 2004
Asbestos death link
News Shopper, UK - Sept, 2004
AN ELDERLY widow's death could be linked to asbestos fibres on the clothes of her son who died four years ago, according to an inquest.
Treatment guides issued for asbestos-related disease
American Medical News - Sept, 2004
The American Thoracic Society published a guide for physicians who are treating nonmalignant diseases related to exposure to asbestos.
University of Iowa settles Old Capitol lawsuit for $1.9 million
Waterloo Cedar Falls Courier, IA - Sep 25, 2004
... 31, 2003, claiming negligence and breach of contract by workers who used open flame torches to remove asbestos from portions of Old Capitol.
Asbestos delaying renovation project at Fox hospital
Oneonta Daily Star, NY - Sep 24, 2004
... needs to be demolished, hospital spokeswoman Maggie Barnes said in May. Before that can be done, however, asbestos needs to be removed from the building.
Asbestos blamed in project tie-ups
Boston Globe, MA - Sep 23, 2004
... The demolition, which was supposed to be completed during the summer, has not gone smoothly, as workers have discovered asbestos in many more places than...
Hope for mesothelioma sufferers
Ninemsn, Australia - Sep 22, 2004
The word mesothelioma sparks fear into potential cancer patients and anger in asbestos sufferers. Long seen as a veritable death ...
Canada blocks asbestos type from global toxic list
Planet Ark, NY - Sep 21, 2004
WASHINGTON - Canada has blocked the addition of a carcinogenic type of asbestos to a global list of toxic chemicals, a move that environmentalists said this ...
GM settled ex-worker's asbestos suit
The St. Louis Post-Dispatch, MO - Sep 21, 2004
... A few months later, Bryson got his lungs tested at a screening for asbestos diseases held at his union hall. The test disclosed ...
New Mesothelioma Treatments
Press World (press release), Russia - Aug 25, 2004
(EMAILWIRE.COM, August 25, 2004) Woodland Hills, CA—Mesothelioma Advisor ( http://www.mesothelioma-advisor.org ) has released a report on new mesothelioma ...
Condesa Launches Blawg Republic
PR Leap (press release), CA - 9 hours ago
... oriented online news service and Asbestos Today (http://www.asbestostoday.com/), an online service that aggregates the latest asbestos and mesothelioma news. ...
02/05/2004
FDA Approves First Drug for Rare Type of Cancer
The Food and Drug Administration (FDA) today approved Alimta (pemetrexed disodium) for use in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma-a rare type of cancer. Alimta received a priority review and is designated as an orphan drug. It is the first drug approved for this condition.
Cancer of the mesothelium, a membrane that covers and protects most of the internal organs of the body is rare; about 2,000 new cases are diagnosed in the United States each year. This form of cancer is usually associated with a history of asbestos exposure. Asbestos fibers lodged in the lung attach to the outer lung lining and chest wall, causing tumors to grow. By the time symptoms appear, the disease is usually advanced, and patients live, on average, nine to thirteen months following diagnosis.
> Read full FDA release
02/2004
Study Supports Development Potential in Several Therapeutic Areas
The study, titled, "Autocrine inhibitory influences of alpha-melanocyte-stimulating hormone in malignant pleural mesothelioma," might provide a novel strategy to reduce mesothelioma cell proliferation.
> Read Full News Article
> Read Abstract for New Study
11/2003
Pacific Northwest Research Institute reported the development of a blood test for mesothelioma.
Seattle-Researchers at the Pacific Northwest Research Institute (PNRI) have reported the development of a blood test for mesothelioma, a highly aggressive lung cancer caused by asbestos exposure.
A PNRI team led by Dr. Ingegerd Hellstrom, and an Australian team, led by Dr. Bruce Robinson, of the University of Western Australia, conducted the research, which appears in the November 15th issue of Lancet. The new test promises a simple technique for diagnosing and monitoring mesothelioma early in its progress, when therapy is more likely to be successful. Fujirebio Diagnostics, Inc. (FDI) of Malvern, PA, a leading oncology diagnostic company, has acquired an exclusive license from PNRI to develop a commercial test for worldwide distribution.
> Read Full News Article
|
|
